Levi & Korsinsky is investigating the Board of Directors of Omnicom Group Inc. (“Omnicom” or the “Company”) (NYSE: OMC) for possible breaches of fiduciary duty and other violations of state law in connection with the proposed merger of the Company with Publicis Groupe (“Publicis”).
Click here to learn more about the investigation http://zlk.9nl.com/omnicom-omc/, or call: 877-363-5972.
Under the terms of the proposed merger, Omnicom shareholders will receive only 0.813 newly issued shares of the new company Publicis Omnicom Group for each share of Omnicom stock they own. Omnicom will also receive a special dividend of $2.00 per share. There may be up to two small subsequent dividends of $0.40 per share, however there is no guarantee of such payments. Publicis shareholders will receive a one full, newly-issued ordinary share of Publicis Omnicom Group for each Publicis share they own. Publicis shareholders will also receive a special dividend of 1.00 euro per share. The transaction has a total approximate value of $35 billion. The investigation concerns whether the Omnicom Board of Directors breached their fiduciary duties to stockholders by failing to adequately maximize the Company’s value before agreeing to enter into this proposed merger, and the fairness of the process by the Company before agreeing to the proposed merger.
If you own common stock in Omnicom and wish to obtain additional information or discuss your rights, please contact Joseph E. Levi, Esq. either via email at firstname.lastname@example.org or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/omnicom-omc/.Levi & Korsinsky is a national firm with offices in New York, New Jersey and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.